fluorouracil has been researched along with endothelin-1 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, S; Moroni, M; Nastasi, G; Porta, C | 1 |
| Feng, KT; Guo, X; Hong, MH; Liang, WJ; Mai, HQ; Mo, HY; Ye, YL; Zeng, ZY; Zhang, CQ | 1 |
| Adstamongkonkul, P; Bawendi, MG; Boucher, Y; Chauhan, VP; Han, X; Huang, P; Jain, RK; Jain, SR; Kozin, SV; Lacorre, DA; Liu, H; Martin, JD; Mousa, AS; Popović, Z; Stylianopoulos, T | 1 |
| El-Abhar, HS; Muhammad, RN; Sallam, N | 1 |
| Adili, A; Aliabadi, P; Asadi, F; Ebrahimzadeh, F; Gusarov, AM; Kharkouei, SA; Mardi, A; Mohammadi, H; Sadri, M; Siri, G; Yazdani, Y | 1 |
5 other study(ies) available for fluorouracil and endothelin-1
| Article | Year |
|---|---|
Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
Topics: Aged; Antimetabolites, Antineoplastic; Coronary Vasospasm; Endothelin-1; Female; Fluorouracil; Heart Diseases; Humans; Male; Middle Aged | 1998 |
Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Atrasentan; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Fluorouracil; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2006 |
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Antineoplastic Agents; Cell Hypoxia; Collagen; Connective Tissue Growth Factor; Drug Repositioning; Drug Synergism; Endothelin-1; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Hyaluronic Acid; Losartan; Mammary Neoplasms, Experimental; Mechanotransduction, Cellular; Mice; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Stress, Mechanical; Stromal Cells; Transforming Growth Factor beta1 | 2013 |
Activated ROCK/Akt/eNOS and ET-1/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin.
Topics: Animals; Antimetabolites, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Endothelin-1; Enzyme Activation; Fluorouracil; Male; MAP Kinase Signaling System; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats, Wistar; rho-Associated Kinases; Signal Transduction; Simvastatin | 2020 |
Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro.
Topics: Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Endothelin-1; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Stomach Neoplasms | 2022 |